Table 2.
Participants’ characteristics and values for selected variables before the first allocation
|
Olmesartan |
Enalapril |
P-value | |
|---|---|---|---|
| (n = 17) | (n = 13) | ||
| Age, years |
60.2 (12.9) |
59.9 (11.6) |
NS |
| Female, n (%) |
8 (47.1) |
2 (15.4) |
<0.0001 |
| BMI, kg/m2 |
27.7 (6.2) |
27.41 (4.1) |
NS |
| Systolic blood pressure, mm Hg |
134.8 (4.2) |
140.1 (4.2) |
NS |
| Diastolic blood pressure, mm Hg |
78.7 (1.7) |
76.2 (1.8) |
NS |
| Dyslipidaemia, n (%) |
6 (35.3) |
5 (38.5) |
NS |
| Serum creatinine, mg/dl |
1.65 (0.07) |
1.60 (0.06) |
NS |
| Glomerular filtration rate, ml/min/1.73 m2 |
42.24 (2.0) |
46.2 (1.9) |
NS |
| Plasma renin activity, ng/ml/h |
1.13 (1.12) |
1.30 (1.46) |
NS |
| Plasma aldosterone, ng/dl |
30.6 (4.0) |
27.1 (5.5) |
NS |
| Diabetic patients, n (%) | 1 (5,8) | 2(15) | NS |
BMI: Body mass index, NS: no significant.
Values are expressed as mean ± SE of the mean.